Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Pediatr Blood Cancer. 2012 Feb 2;59(5):934–938. doi: 10.1002/pbc.24103

Figure 1.

Figure 1

(A) Patient 7 at birth. He was misdiagnosed as an IH and started on propranolol 2 mg/kg/day at 17 days. (B) KHE after 11 days of propranolol monotherapy. His KHE and KMP worsened during the 19 days that he was on propranolol, despite the addition of prednisolone 2 mg/kg/day. (C) Patient 9 at 4 months of age. She was also misdiagnosed as an IH at birth and started on propranolol with stabilization of growth and thrombocytopenia. The propranolol was discontinued at 3 months of age as the tumor was thought to be quiescent. Within 1 month, she presented with an enlarging tumor and platelet count of 5,000/μL and was diagnosed with TA and KMP. (D) TA at 8 months of age, 4 months into second course of propranolol. Treatment with propranolol rapidly decreased tumor size within 24 hours of achieving 3 mg/kg/day and normalization of platelet count within 2 weeks. She was treated for an additional 8 months with complete resolution of her TA and KMP.